Literature DB >> 12697910

What is osteoporosis?

C Christodoulou1, C Cooper.   

Abstract

Osteoporosis is a very common disorder, which results in an increase in fracture risk. The annual cost attributable to hip, vertebral, and wrist fractures in England and Wales is pound 1.7 billion. Significant mortality and morbidity are associated with osteoporotic fractures. The method that is most widely used for the diagnosis of osteoporosis is dual energy x-ray absorptiometry. The aim of prevention and treatment of osteoporosis is to prevent the occurrence of future fractures. Lifestyle changes should be encouraged in high risk patients. Pharmacological treatments include the bisphosphonates, hormone replacement therapy, selective oestrogen receptor modulators, calcitonin, the 1-34 fragment of parathyroid hormone, calcium and vitamin D supplements, and calcitriol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697910      PMCID: PMC1742639          DOI: 10.1136/pmj.79.929.133

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  35 in total

1.  Prevention and treatment of osteoporosis. Clinical guidelines and new evidence.

Authors:  J Compston
Journal:  J R Coll Physicians Lond       Date:  2000 Nov-Dec

2.  Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.

Authors:  Anthony B Hodsman; David A Hanley; Robert Josse
Journal:  CMAJ       Date:  2002-05-28       Impact factor: 8.262

Review 3.  A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update.

Authors:  R Eastell; D M Reid; J Compston; C Cooper; I Fogelman; R M Francis; D J Hosking; D W Purdie; S H Ralston; J Reeve; R G Russell; J C Stevenson; D J Torgerson
Journal:  J Intern Med       Date:  1998-10       Impact factor: 8.989

Review 4.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

Review 5.  Epidemiology of fractures and assessment of fracture risk.

Authors:  D M Black; C Cooper
Journal:  Clin Lab Med       Date:  2000-09       Impact factor: 1.935

6.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

7.  A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.

Authors:  J D Adachi; C Roux; P I Pitt; C Cooper; C Moniz; J Dequeker; G Ioannidis; M I Cawley; E A Jenkins; K E Walker-Bone; S Pack; G F Stephenson; R F Laan; J Brown; P Geusens
Journal:  J Rheumatol       Date:  2000-10       Impact factor: 4.666

8.  Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy.

Authors:  Fiona Wu; Ruth Ames; Judy Clearwater; Margaret C Evans; Greg Gamble; Ian R Reid
Journal:  Clin Endocrinol (Oxf)       Date:  2002-06       Impact factor: 3.478

Review 9.  Treatment of postmenopausal osteoporosis.

Authors:  Pierre D Delmas
Journal:  Lancet       Date:  2002-06-08       Impact factor: 79.321

10.  Performance evaluation of a dual-energy x-ray bone densitometer.

Authors:  R Mazess; B Collick; J Trempe; H Barden; J Hanson
Journal:  Calcif Tissue Int       Date:  1989-03       Impact factor: 4.333

View more
  19 in total

Review 1.  Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential.

Authors:  Richard O C Oreffo; Cyrus Cooper; Christopher Mason; Mark Clements
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

2.  Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: findings from post-menopausal Japanese female subjects.

Authors:  M Sugiura; M Nakamura; K Ogawa; Y Ikoma; F Ando; H Shimokata; M Yano
Journal:  Osteoporos Int       Date:  2010-05-18       Impact factor: 4.507

3.  Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study.

Authors:  N M van Schoor; J H Smit; J W R Twisk; P Lips
Journal:  Osteoporos Int       Date:  2004-10-12       Impact factor: 4.507

4.  The effect of behavioural risk factors on osteoporosis in Irish women.

Authors:  N M Cummins; P M Jakeman; I Sestak; N Murphy; P Carroll
Journal:  Ir J Med Sci       Date:  2012-07-28       Impact factor: 1.568

Review 5.  Calcium use in the management of osteoporosis: continuing questions and controversies.

Authors:  Cory Wilczynski; Pauline Camacho
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

6.  Bone mineral density in post-menopausal female subjects is associated with serum antioxidant carotenoids.

Authors:  M Sugiura; M Nakamura; K Ogawa; Y Ikoma; F Ando; M Yano
Journal:  Osteoporos Int       Date:  2007-09-11       Impact factor: 4.507

7.  Knowledge change regarding osteoporosis prevention: translating recommended guidelines into user-friendly messages within a community forum.

Authors:  Sarah M Hosking; Amelia G Dobbins; Julie A Pasco; Sharon L Brennan
Journal:  BMC Res Notes       Date:  2015-02-08

8.  High serum carotenoids associated with lower risk for bone loss and osteoporosis in post-menopausal Japanese female subjects: prospective cohort study.

Authors:  Minoru Sugiura; Mieko Nakamura; Kazunori Ogawa; Yoshinori Ikoma; Masamichi Yano
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene sequencing and by microbiological culture.

Authors:  Kate E Dempsey; Marcello P Riggio; Alan Lennon; Victoria E Hannah; Gordon Ramage; David Allan; Jeremy Bagg
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial.

Authors:  Tim D Spector; Mario R Calomme; Simon H Anderson; Gail Clement; Liisa Bevan; Nathalie Demeester; Rami Swaminathan; Ravin Jugdaohsingh; Dirk A Vanden Berghe; Jonathan J Powell
Journal:  BMC Musculoskelet Disord       Date:  2008-06-11       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.